Managing chronic hepatitis C acquired through intravenous drug use

Intravenous Drug Use and Hepatitis C Virus in Iran

1 Department of Internal Medicine, Kermanshah University of Medical Sciences, School of Medicine, Imam Reza Hospital, Kermanshah, IR Iran 2 Department of Gastroenterology, Isfahan University of Medical Sciences, Isfahan, IR Iran 3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran Hepat Mon.2012: 9-10. DOI: 10.5812/...

intravenous drug use and hepatitis c virus in iran

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.

SUMMARY Reluctance has been expressed about treating chronic hepatitis C in active intravenous (IV) drug users (IDUs), and this is found in both international guidelines and routine clinical practice. However, the medical literature provides no evidence for an unequivocal treatment deferral of this risk group. We retrospectively analyzed the direct effect of IV drug use on treatment outcome in ...

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran

I read with interest the published article by Ranjbar Kermani et al. (1). Genotyping of hepatitis C virus (HCV) is important, which provides information about strain variation and characteristics of virus during the treatment and the therapy response rate (2). In addition, it is of epidemiologic value because it sheds light on whether prevalent HCV strains are similar to that endemic ones in a ...

hepatitis c genotypes distribution in intravenous drug users in tehran